A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy

Arnold Angelo M. Pineda, Katsuya Ogata, Manabu Osoegawa, Hiroyuki Murai, Hiroshi Shigeto, Takashi Yoshiura, Shozo Tobimatsu, Jun ichi Kira

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

To explore subclinical central nervous system (CNS) involvement in chronic inflammatory demyelinating polyneuropathy (CIDP), we recorded somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) using transcranial magnetic stimulation, to measure central sensory conduction time (CSCT) and central motor conduction time (CMCT) and examined brain and spinal cord MRI in patients with probable CIDP based on the American Academy of Neurology AIDS Task Force criteria. Eighteen patients with probable CIDP (12 males and 6 females; mean age at examination ± SD, 45.8 ± 17.0 years; range, 17-72) were included in the study. Of the 13 patients who underwent SEPs, one had prolonged CSCT (8%) and of the 13 who underwent MEPs, four had abnormal CMCT (31%). Cranial MRI revealed five of 18 patients had abnormal scans, only one of which showed multiple ovoid periventricular lesions suggestive of demyelination while none showed any intramedullary lesion on spinal cord MRI. Thus, 6 of the 18 patients were considered to have subclinical demyelinative CNS involvement which had lower disability on Global Neurological Disability Score (GNDS) (p = 0.0061), a male preponderance (0.0537) and a larger compound muscle action potential (CMAP) amplitude in the median nerve (p = 0.005) than those without. The decrease of GNDS with immunologic therapies was nearly significant in the former (p = 0.0556) but not in the latter. The results of the present study suggest that subclinical CNS involvement in CIDP is not uncommon in Japanese patients and that CIDP with subclinical CNS involvement is more demyelinative thus responsive to immunotherapies while those without have more axonal damage and less responsive to immunotherapies.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalJournal of the Neurological Sciences
Volume255
Issue number1-2
DOIs
Publication statusPublished - Apr 15 2007

Fingerprint

Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Demyelinating Diseases
Immunotherapy
Central Nervous System
Motor Evoked Potentials
Somatosensory Evoked Potentials
Spinal Cord
Transcranial Magnetic Stimulation
Median Nerve
Advisory Committees
Action Potentials
Acquired Immunodeficiency Syndrome
Muscles
Brain

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy. / Pineda, Arnold Angelo M.; Ogata, Katsuya; Osoegawa, Manabu; Murai, Hiroyuki; Shigeto, Hiroshi; Yoshiura, Takashi; Tobimatsu, Shozo; Kira, Jun ichi.

In: Journal of the Neurological Sciences, Vol. 255, No. 1-2, 15.04.2007, p. 1-6.

Research output: Contribution to journalArticle

@article{4b5064e87729463ca30401b97315073d,
title = "A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy",
abstract = "To explore subclinical central nervous system (CNS) involvement in chronic inflammatory demyelinating polyneuropathy (CIDP), we recorded somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) using transcranial magnetic stimulation, to measure central sensory conduction time (CSCT) and central motor conduction time (CMCT) and examined brain and spinal cord MRI in patients with probable CIDP based on the American Academy of Neurology AIDS Task Force criteria. Eighteen patients with probable CIDP (12 males and 6 females; mean age at examination ± SD, 45.8 ± 17.0 years; range, 17-72) were included in the study. Of the 13 patients who underwent SEPs, one had prolonged CSCT (8{\%}) and of the 13 who underwent MEPs, four had abnormal CMCT (31{\%}). Cranial MRI revealed five of 18 patients had abnormal scans, only one of which showed multiple ovoid periventricular lesions suggestive of demyelination while none showed any intramedullary lesion on spinal cord MRI. Thus, 6 of the 18 patients were considered to have subclinical demyelinative CNS involvement which had lower disability on Global Neurological Disability Score (GNDS) (p = 0.0061), a male preponderance (0.0537) and a larger compound muscle action potential (CMAP) amplitude in the median nerve (p = 0.005) than those without. The decrease of GNDS with immunologic therapies was nearly significant in the former (p = 0.0556) but not in the latter. The results of the present study suggest that subclinical CNS involvement in CIDP is not uncommon in Japanese patients and that CIDP with subclinical CNS involvement is more demyelinative thus responsive to immunotherapies while those without have more axonal damage and less responsive to immunotherapies.",
author = "Pineda, {Arnold Angelo M.} and Katsuya Ogata and Manabu Osoegawa and Hiroyuki Murai and Hiroshi Shigeto and Takashi Yoshiura and Shozo Tobimatsu and Kira, {Jun ichi}",
year = "2007",
month = "4",
day = "15",
doi = "10.1016/j.jns.2007.01.004",
language = "English",
volume = "255",
pages = "1--6",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy

AU - Pineda, Arnold Angelo M.

AU - Ogata, Katsuya

AU - Osoegawa, Manabu

AU - Murai, Hiroyuki

AU - Shigeto, Hiroshi

AU - Yoshiura, Takashi

AU - Tobimatsu, Shozo

AU - Kira, Jun ichi

PY - 2007/4/15

Y1 - 2007/4/15

N2 - To explore subclinical central nervous system (CNS) involvement in chronic inflammatory demyelinating polyneuropathy (CIDP), we recorded somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) using transcranial magnetic stimulation, to measure central sensory conduction time (CSCT) and central motor conduction time (CMCT) and examined brain and spinal cord MRI in patients with probable CIDP based on the American Academy of Neurology AIDS Task Force criteria. Eighteen patients with probable CIDP (12 males and 6 females; mean age at examination ± SD, 45.8 ± 17.0 years; range, 17-72) were included in the study. Of the 13 patients who underwent SEPs, one had prolonged CSCT (8%) and of the 13 who underwent MEPs, four had abnormal CMCT (31%). Cranial MRI revealed five of 18 patients had abnormal scans, only one of which showed multiple ovoid periventricular lesions suggestive of demyelination while none showed any intramedullary lesion on spinal cord MRI. Thus, 6 of the 18 patients were considered to have subclinical demyelinative CNS involvement which had lower disability on Global Neurological Disability Score (GNDS) (p = 0.0061), a male preponderance (0.0537) and a larger compound muscle action potential (CMAP) amplitude in the median nerve (p = 0.005) than those without. The decrease of GNDS with immunologic therapies was nearly significant in the former (p = 0.0556) but not in the latter. The results of the present study suggest that subclinical CNS involvement in CIDP is not uncommon in Japanese patients and that CIDP with subclinical CNS involvement is more demyelinative thus responsive to immunotherapies while those without have more axonal damage and less responsive to immunotherapies.

AB - To explore subclinical central nervous system (CNS) involvement in chronic inflammatory demyelinating polyneuropathy (CIDP), we recorded somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) using transcranial magnetic stimulation, to measure central sensory conduction time (CSCT) and central motor conduction time (CMCT) and examined brain and spinal cord MRI in patients with probable CIDP based on the American Academy of Neurology AIDS Task Force criteria. Eighteen patients with probable CIDP (12 males and 6 females; mean age at examination ± SD, 45.8 ± 17.0 years; range, 17-72) were included in the study. Of the 13 patients who underwent SEPs, one had prolonged CSCT (8%) and of the 13 who underwent MEPs, four had abnormal CMCT (31%). Cranial MRI revealed five of 18 patients had abnormal scans, only one of which showed multiple ovoid periventricular lesions suggestive of demyelination while none showed any intramedullary lesion on spinal cord MRI. Thus, 6 of the 18 patients were considered to have subclinical demyelinative CNS involvement which had lower disability on Global Neurological Disability Score (GNDS) (p = 0.0061), a male preponderance (0.0537) and a larger compound muscle action potential (CMAP) amplitude in the median nerve (p = 0.005) than those without. The decrease of GNDS with immunologic therapies was nearly significant in the former (p = 0.0556) but not in the latter. The results of the present study suggest that subclinical CNS involvement in CIDP is not uncommon in Japanese patients and that CIDP with subclinical CNS involvement is more demyelinative thus responsive to immunotherapies while those without have more axonal damage and less responsive to immunotherapies.

UR - http://www.scopus.com/inward/record.url?scp=33947205497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947205497&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.01.004

DO - 10.1016/j.jns.2007.01.004

M3 - Article

C2 - 17306302

AN - SCOPUS:33947205497

VL - 255

SP - 1

EP - 6

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -